MREO
NASDAQ
GB
Mereo BioPharma Group plc - American Depositary Shares
$0.32
▼ $-0.01
(-3.03%)
Vol 2.3M
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$66.3M
ROE
-75.2%
D/E
0.00
Beta
0.20
52W
$1–$4
Wall Street Consensus
14 analysts · Apr 20265
Strong Buy
5
Buy
4
Hold
0
Sell
0
Strong Sell
71.4%
Buy Rating
Price Chart
Earnings
Beat rate: 40.0%
Next Report
May 11, 2026
EPS Estimate: $-0.01
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.01 | — | — |
| Dec 2025 | $-0.01 | $-0.01 | +$0.00 |
| Sep 2025 | $-0.02 | $-0.01 | +$0.01 |
| Jun 2025 | $-0.02 | $-0.10 | $-0.08 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | $500K | — |
| Net Income | -$15.0M | -$7.0M | -$12.9M | -$14.6M | -$7.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -80.2% | -80.9% | -80.2% | -80.2% | -80.2% | -75.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 8.13 | 8.07 | 8.13 | 8.13 | 8.13 | 8.71 |
Key Ratios
ROA (TTM)
-63.9%
P/B
8.9
EPS (TTM)
$-0.05
CF/Share
$-4.46
52W High
$3.88
52W Low
$1.47
$1.47
52-Week Range
$3.88
Financial Health
Free Cash Flow
-$7.3M
Net Debt
-$48.3M
Cash
$48.7M
Total Debt
$397K
As of Sep 30, 2025
How does MREO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MREO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
8.9
▲
262%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MREO profitability vs Biotechnology peers
ROE
-75.2%
▼
12%
below
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-63.9%
▼
37%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
MREO financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.7
▲
96%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.2
▼
80%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
MREO fundamentals radar
MREO
Peer median
Industry
MREO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MREO vs peers: key metrics
Latest News
No related news yet